Image de couverture de For Blood and Money

For Blood and Money

Billionaires, Biotech, and the Quest for a Blockbuster Drug

Écouter un extrait
La meilleure offre de la saison

0,99 €/mois pendant 3 mois + 15 € de crédit Audible

Renouvellement automatique à 6,99 €/mois après 3 mois. Annulation mensuelle possible.
Profiter de l’offre
L'offre prend fin le 28 décembre 2026.
Plus d'offres

For Blood and Money

De : Nathan Vardi
Lu par : Rob Shapiro
Profiter de l’offre

Renouvellement automatique à 6,99 €/mois après 3 mois. Annulation mensuelle possible. L'offre se termine le 28 décembre 2026.

Acheter pour 17,89 €

Acheter pour 17,89 €

La meilleure offre de la saison | 0,99 €/mois pendant les 3 premiers mois + 15 € de crédit Audible

6,99 €/mois par la suite. Des conditions s’appliquent. Annulation mensuelle possible.
À propos de ce titre

A gripping business narrative and scientific thriller about what it takes to bring a wonder drug to market—and save countless lives.

For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug and how the core team—denied their share of the profits—went and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time.

In the multibillion-dollar business of biotech, where pharmaceutical companies, the government, hedge funds, and venture capitalists have spent billions on funding, experimentation, and treatments, a single molecule can stop cancer in its tracks—and make the people who find that rare molecule astonishingly rich. For Blood and Money follows a small team at a biotech start-up in California, who have found one of these rare molecules. Their compound, known as a BTK inhibitor, seems to work on a vicious type of leukemia. When patients start rising from their hospice beds, the team knows they’re onto something big.

What follows is a story of genius, pathos, and drama, in which vivid characters navigate a world of corporate intrigue and ambiguous morality. Vardi’s narrative immerses listeners in the recent explosion of biotech start-ups. He describes the scientists, doctors, and investors who are risking everything to develop new, life-saving treatments, and introduces suffering patients for whom the stakes are life-or-death. A gripping nonfiction listen, For Blood and Money illustrates why it’s so hard to bring new drugs to market, explains why they are so expensive, and examines how profit-driven venture capitalists are shaping the future of medicine.

©2023 Nathan Vardi (P)2023 Audible, Inc.

Ces titres pourraient aussi vous intéresser

Image de couverture de 1929
Image de couverture de The Billion Dollar Molecule
Image de couverture de How Progress Ends
Image de couverture de Bad Blood
Image de couverture de Bottle of Lies
Image de couverture de From Breakthrough to Blockbuster
Image de couverture de Debt - Updated and Expanded
Image de couverture de Incorruptible
Image de couverture de The Nvidia Way
Image de couverture de Thinking, Fast and Slow
Image de couverture de The Outsiders
Image de couverture de The Hard Thing About Hard Things
Image de couverture de 33 Strategies of War
Image de couverture de Breaking Through
Image de couverture de Managing Oneself
Image de couverture de Protocols
adbl_web_anon_alc_button_suppression_t1
Toutes les étoiles
Les plus pertinentes
This book being about pharma is something new. Especially interesting if you work in the healthcare field.

Couldn't stop listening

Une erreur s'est produite. Veuillez réessayer dans quelques minutes.

Great book, specially if you work in the Biotech environment.
It describes 2 drugs and the stories behind them. With winners and losers.
Very objective point of view.

Great book, specially if you work in the Biotech environment.

Une erreur s'est produite. Veuillez réessayer dans quelques minutes.

I’m in the biotech finance industry and love the storytelling of events I lived through. It was read in a way that’s easily accessible also for those simply interested in the business side of drug development. I couldn’t stop listening!

Stayed up hours listening

Une erreur s'est produite. Veuillez réessayer dans quelques minutes.

nice and in depth hisotry of drug development for chronic leukemias and lymphomas. well researched.

interrestong

Une erreur s'est produite. Veuillez réessayer dans quelques minutes.

Great and inspiring overview of the path of the biotech entrepreneur - with all the details about the difficulties along the way. Loved the personal stories - these made the whole story so much more human. Great hear!

Great for biotech enthusiasts

Une erreur s'est produite. Veuillez réessayer dans quelques minutes.